2024 Q1 Form 10-K Financial Statement

#000149315224011808 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $512.6K $839.4K $1.530M
YoY Change 1505.75% 2048.92% 1212.96%
Cost Of Revenue $475.2K $747.3K $1.289M
YoY Change 2305.13% -46805.0% 2162.92%
Gross Profit $37.46K $92.09K $240.5K
YoY Change 207.82% 126.49% 303.98%
Gross Profit Margin 7.31% 10.97% 15.72%
Selling, General & Admin $2.741M $3.641M $14.98M
YoY Change 2.51% -3.12% 101.75%
% of Gross Profit 7318.17% 3953.6% 6228.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $383.2K $89.74K $1.110M
YoY Change 96.52% -292.95% 129.25%
% of Gross Profit 1022.93% 97.45% 461.41%
Operating Expenses $3.677M $3.641M $14.98M
YoY Change 3.81% -3.12% 16.73%
Operating Profit -$3.639M -$3.549M -$14.74M
YoY Change 3.1% -4.54% 15.39%
Interest Expense $123.6K -$147.3K -$374.2K
YoY Change -25.14% 144.82% -176.56%
% of Operating Profit
Other Income/Expense, Net -$75.19K $44.67K $184.6K
YoY Change -1225.95% 418.82% -22.88%
Pretax Income -$3.715M -$3.659M -$14.93M
YoY Change 5.43% 5.54% 19.1%
Income Tax
% Of Pretax Income
Net Earnings -$3.715M -$3.659M -$14.93M
YoY Change 5.43% 5.54% 19.1%
Net Earnings / Revenue -724.62% -435.92% -975.99%
Basic Earnings Per Share -$0.18 -$0.84
Diluted Earnings Per Share -$0.18 -$0.19 -$0.84
COMMON SHARES
Basic Shares Outstanding 24.10M shares 19.43M shares 17.69M shares
Diluted Shares Outstanding 21.19M shares 17.69M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.537M $3.366M $3.366M
YoY Change -66.28% -76.98% -76.98%
Cash & Equivalents $3.537M $3.366M $3.366M
Short-Term Investments
Other Short-Term Assets $342.2K $1.497M $1.497M
YoY Change -84.72% -26.4% -26.4%
Inventory $6.540M $3.631M $3.631M
Prepaid Expenses
Receivables $156.3K $463.1K $463.1K
Other Receivables $155.3K $165.9K $165.9K
Total Short-Term Assets $10.74M $9.124M $9.124M
YoY Change -26.93% -50.23% -50.23%
LONG-TERM ASSETS
Property, Plant & Equipment $14.31M $15.40M $15.40M
YoY Change 11.89% 29.41% 17.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $90.73K $90.73K $90.73K
YoY Change 0.0% 271.54% 271.54%
Other Assets
YoY Change
Total Long-Term Assets $16.55M $16.83M $16.83M
YoY Change 7.5% 16.62% 16.62%
TOTAL ASSETS
Total Short-Term Assets $10.74M $9.124M $9.124M
Total Long-Term Assets $16.55M $16.83M $16.83M
Total Assets $27.29M $25.95M $25.95M
YoY Change -9.32% -20.79% -20.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.262M $1.451M $1.451M
YoY Change 11.89% -28.45% -28.45%
Accrued Expenses $281.7K $413.2K $413.2K
YoY Change -31.15% 6.69% 6.69%
Deferred Revenue
YoY Change
Short-Term Debt $5.300M $5.302M $5.302M
YoY Change 241909.13% 11401.5% 11401.5%
Long-Term Debt Due $5.300M
YoY Change
Total Short-Term Liabilities $7.844M $7.167M $7.167M
YoY Change 222.41% 191.12% 191.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $546.6K $608.8K $608.8K
YoY Change -29.95% -31.15% -31.15%
Total Long-Term Liabilities $546.6K $608.8K $608.8K
YoY Change -91.01% -90.16% -90.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.844M $7.167M $7.167M
Total Long-Term Liabilities $546.6K $608.8K $608.8K
Total Liabilities $8.390M $7.775M $7.775M
YoY Change -1.44% -10.07% -10.07%
SHAREHOLDERS EQUITY
Retained Earnings -$52.03M -$48.31M
YoY Change 40.97% 44.72%
Common Stock $2.410K $2.032K
YoY Change 40.44% 18.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.90M $18.18M $18.18M
YoY Change
Total Liabilities & Shareholders Equity $27.29M $25.95M $25.95M
YoY Change -9.32% -20.79% -20.79%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$3.715M -$3.659M -$14.93M
YoY Change 5.43% 5.54% 19.1%
Depreciation, Depletion And Amortization $383.2K $89.74K $1.110M
YoY Change 96.52% -292.95% 129.25%
Cash From Operating Activities -$2.795M -$3.741M -$11.93M
YoY Change -4.76% 131.41% 49.54%
INVESTING ACTIVITIES
Capital Expenditures $213.0K $240.1K $3.690M
YoY Change -80.41% -74.42% -66.6%
Acquisitions
YoY Change
Other Investing Activities $0.00 $3.690K -$66.31K
YoY Change -100.0%
Cash From Investing Activities -$213.0K -$246.4K -$3.756M
YoY Change -81.53% -73.75% -66.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.476M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.179M 4.382M 4.432M
YoY Change -7340.29% -4331.74% -14.48%
NET CHANGE
Cash From Operating Activities -$2.795M -3.741M -11.93M
Cash From Investing Activities -$213.0K -246.4K -3.756M
Cash From Financing Activities $3.179M 4.382M 4.432M
Net Change In Cash $171.2K 395.0K -11.25M
YoY Change -104.14% -114.86% -19.3%
FREE CASH FLOW
Cash From Operating Activities -$2.795M -$3.741M -$11.93M
Capital Expenditures $213.0K $240.1K $3.690M
Free Cash Flow -$3.008M -$3.981M -$15.62M
YoY Change -25.21% 55.8% -17.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001096275
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 WKSP Stock Issued During Period Value Share Issuance
StockIssuedDuringPeriodValueShareIssuance
usd
CY2022 WKSP Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
usd
CY2023 WKSP Accrued Interest
AccruedInterest
usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
usd
CY2023 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
usd
CY2023 WKSP Cashless Warrant Exercise
CashlessWarrantExercise
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
usd
CY2023 WKSP Income Tax Reconciliation Interest And Penalty
IncomeTaxReconciliationInterestAndPenalty
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 WKSP Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2023 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Expired In Period Weighted Average Expirations Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredInPeriodWeightedAverageExpirationsPrice
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
35688619 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24100413 shares
CY2023 dei Auditor Name
AuditorName
Lumsden & McCormick, LLP
CY2023 dei Auditor Location
AuditorLocation
Buffalo, New York
CY2023 dei Auditor Firm
AuditorFirmId
130
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3365778 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14620757 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
463122 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62601 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
165865 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
268032 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3631492 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1346372 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1497249 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2034345 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9123506 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18332107 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
90731 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
24423 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14483436 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11900672 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
917354 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1238055 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1338889 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1268873 usd
CY2023Q4 us-gaap Assets
Assets
25953916 usd
CY2022Q4 us-gaap Assets
Assets
32764130 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1451181 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2028305 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
85010 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
5300000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
328229 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
387329 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7166612 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2461730 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
608761 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
884146 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
5300000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7775373 usd
CY2022Q4 us-gaap Liabilities
Liabilities
8645876 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
299000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
299000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17159376 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17159376 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2032 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1716 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64685693 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56919625 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
1577 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
1577 usd
CY2023Q4 WKSP Share Subscriptions Payable
ShareSubscriptionsPayable
1814152 usd
CY2022Q4 WKSP Share Subscriptions Payable
ShareSubscriptionsPayable
591289 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48313177 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33384219 usd
CY2023Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-8580 usd
CY2022Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-8580 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18178543 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24118254 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25953916 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32764130 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1529632 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116502 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9643680 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4978582 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1483054 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2446266 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
3853134 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
5418863 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2693 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10461 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
14977175 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
12833250 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-14736661 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-12773715 usd
CY2023 us-gaap Interest Expense
InterestExpense
616214 usd
CY2022 us-gaap Interest Expense
InterestExpense
488704 usd
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
239353 usd
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
212290 usd
CY2023 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
184564 usd
CY2022 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
213383 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
302332 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-192297 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
239301 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14928958 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12534414 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17689911 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17689911 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17078480 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17078480 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34180322 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2472346 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12534414 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24118254 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24118254 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4493972 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4475780 usd
CY2023 WKSP Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
89 usd
CY2023 WKSP Adjustments To Additional Paid In Capital Stock Option Forfeiture
AdjustmentsToAdditionalPaidInCapitalStockOptionForfeiture
19406 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14928958 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18178543 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4899433 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18178543 usd
CY2023 us-gaap Profit Loss
ProfitLoss
14928958 usd
CY2022 us-gaap Profit Loss
ProfitLoss
12534414 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5754717 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14928958 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12534414 usd
CY2023Q4 WKSP Working Capital
WorkingCapital
1 usd
CY2022Q4 WKSP Working Capital
WorkingCapital
15870377 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1109742 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
486582 usd
CY2023 WKSP Change In Operating Lease
ChangeInOperatingLease
13784 usd
CY2022 WKSP Change In Operating Lease
ChangeInOperatingLease
-10584 usd
CY2022 WKSP Accrued Interest
AccruedInterest
27564 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
302332 usd
CY2023 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-8078283 usd
CY2022 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-7412583 usd
CY2023 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3852297 usd
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
565377 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11930580 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7977960 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
66308 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
103329 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3690056 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11047447 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3756364 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11150776 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4475869 usd
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
5300000 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-43904 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
10547 usd
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
128387 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4431965 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5182160 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11254979 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13946576 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14620757 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28567333 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3365778 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14620757 usd
CY2023 WKSP Purchase Of Software
PurchaseOfSoftware
72466 usd
CY2022 WKSP Purchase Of Software
PurchaseOfSoftware
575000 usd
CY2022 WKSP Cashless Warrant Exercise
CashlessWarrantExercise
37000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
626000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
479000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80A_eus-gaap--NatureOfOperations_zON6jCloweLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82C_zxQXk6MoHfYe">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Worksport Ltd. (together with its subsidiaries, the “Company”) was incorporated in the State of Nevada on April 2, 2003 under the name Franchise Holdings International, Inc. (“FNHI”). In May 2020, FNHI changed its name to Worksport Ltd. During the year ended December 31, 2014, the Company completed a reverse acquisition transaction (the “Reverse Acquisition”) with TruXmart Ltd. (“TruXmart”). On May 2, 2018, Truxmart legally changed its name to Worksport Ltd. (“Worksport”). Worksport designs and distributes truck tonneau covers in Canada and the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terravis Energy, Inc. (“Terravis”) was incorporated in the State of Colorado on May 5, 2021. On August 20, 2021, the Company was issued <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210820__dei--LegalEntityAxis__custom--TerravisEnergyIncMember_zem2DSrWMK3c" title="Common stock, shares issued">100</span> common shares at par value of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210820__dei--LegalEntityAxis__custom--TerravisEnergyIncMember_zI0VkbuiaT14" title="Common stock, par or stated value per share">0.0001</span> per share for a controlling interest in Terravis. During the year ended December 31, 2022, the Company was issued an additional <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__dei--LegalEntityAxis__custom--TerravisEnergyIncMember_z3lmSuII1Ds4" title="Common stock, shares issued">9,990,900</span> common shares of Terravis at par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231__dei--LegalEntityAxis__custom--TerravisEnergyIncMember_z5LPe84ZSyFl" title="Common stock, par or stated value per share">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 20, 2022, the board of directors of Terravis and the board of directors of the Company, as the sole stockholder of Terravis, adopted the Terravis Energy, Inc. 2022 Equity Incentive Plan (the “Terravis 2022 Plan”). Under the Terravis 2022 Plan, Terravis’ board of directors or a committee designated by the board of directors may grant incentive stock options, nonqualified stock options, shares of restricted stock, restricted stock units, performance shares, performance units and stock appreciation rights to eligible participants consisting of employees of Terravis, member of Terravis’ board of directors and advisors and consultants to Terravis. The Terravis board of directors authorized and reserved <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220120__us-gaap--PlanNameAxis__custom--TerravisTwoThousandTwentyTwoPlanMember_z2SdP2BKd0vb" title="Common stock, shares authorized">1,500,000</span> shares of Terravis common stock under the Terravis 2022 Plan, subject to adjustment for any stock splits of Terravis’s common stock or reorganization, recapitalization, or acquisition of Terravis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 6, 2022, Terravis issued Lorenzo Rossi and Steven Rossi, both of whom are members of Terravis’s board of directors, were granted non-qualified stock options under the Terravis 2022 Plan exercisable for <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220406__srt--TitleOfIndividualAxis__custom--LorenzoRossiMember_zgiH9twqLLYk" title="Number of options, exercisable">750,000</span> and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220406__srt--TitleOfIndividualAxis__custom--StevenRossiMember_zDVIEfhO2WF1" title="Number of options, exercisable">250,000</span> shares of Terravis’s common stock, respectively, with exercise prices of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220406_zYchrssoqre5" title="Common stock, par value">0.01</span> per share exercisable from the date of grant until the tenth anniversary of the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2022, Steven Rossi, William Caragol, and Ned L. Siegel, all of whom are members of Terravis’s board of directors, were granted non-qualified stock options under the Terravis 2022 Plan exercisable for <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220412__srt--TitleOfIndividualAxis__custom--StevenRossiMember_zjahTj88HbJd" title="Number of options, exercisable">250,000</span>, <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220412__srt--TitleOfIndividualAxis__custom--WilliamCaragolMember_znseb7Syujta" title="Number of options, exercisable">50,000</span>, and <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220412__srt--TitleOfIndividualAxis__custom--NedLSiegelMember_zoWQ9e9P66h8" title="Number of options, exercisable">50,000</span> shares of Terravis’s common stock, respectively, with exercise prices of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220412_zCaiylmYyCu7" title="Common stock, par value">0.01</span> per share exercisable from the date of grant until the tenth anniversary of the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2022, Terravis filed an amendment to its articles of incorporation with the Colorado Secretary of State, pursuant to which the Terravis board of directors attached a certificate of designation designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zDpz5tYfaaCj" title="Preferred stock, shares authorized">1,000</span> shares of its authorized preferred stock as Series A Preferred Stock with a par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zNHStQxFhLni" title="Preferred stock, par value">0.0001</span> per share. According to the certificate of designation, holders of the Series A Preferred Stock do not have any dividend, conversion or liquidation rights. Unless otherwise prohibited by law or the Series A Preferred Stock certificate of designation, the Series A Preferred Stock shall vote together with the outstanding shares of common stock of Terravis as one class on any matter put forth before the common stockholders. For so long the Series A Preferred Stock is outstanding, the holders of the Series A Preferred Stock shall be entitled to <span id="xdx_902_ecustom--SeriesAPreferredStockOutstandingPercentage_pid_dp_uPure_c20221103__20221104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zmr5C6chxOA8" title="Preferred stock, shares outstanding percentage">51</span>% of the total votes on all matters regardless of the actual number of shares of Series A Preferred Stock then outstanding, and the holders of the common stock and any other shares of capital stock of Terravis entitled shall be entitled to their proportional share of the remaining <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20221104__us-gaap--BusinessAcquisitionAxis__custom--TerravisEnergyIncMember_zThseA1PzPek" title="Voting percentage">49</span>% of the total votes based on their respective voting power. On November 4, 2022, the Company issued <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zKnnUMTNAz27" title="Preferred stock, shares authorized">1,000</span> shares of Series A Preferred Stock to Lorenzo Rossi, the President of Terravis and the Chief Executive Officer and President of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, Worksport New York Operations Corporation and Worksport USA Operations Corporation were incorporated in the state of New York and Colorado, respectively. During the year ended, the Company was issued <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__dei--LegalEntityAxis__custom--WorksportUSAOperationsMember_zydDfTFLok9j" title="Common stock, shares, issued">1,000</span> common shares at par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231__dei--LegalEntityAxis__custom--WorksportUSAOperationsMember_zK42mgxOuJD9" title="Common stock, par value">0.0001</span> of Worksport USA Operations Corporation. On April 1, 2022, the Company was issued <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20220401_zz6q7vAvxXTk" title="Common stock, shares, issued">10,000</span> common shares of Worksport New York Operations Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Worksport Ltd.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023 and 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10000 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3365778 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48313177 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48313177 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33384219 usd
CY2023Q4 WKSP Working Capital
WorkingCapital
1 usd
CY2022Q4 WKSP Working Capital
WorkingCapital
15870377 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48313177 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33384219 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3365778 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14620757 usd
CY2023 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
32500000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p id="xdx_84C_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zH931BQiuZ42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zWdUZNqXWLg8">Warranties</span> - </b>The Company currently offers a limited lifetime warranty against defective products out-of-the-box. Customers who are not satisfied with their purchase may attempt to have their purchases reimbursed outside of the warranty period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1717669 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1200759 usd
CY2023Q4 us-gaap Other Inventory
OtherInventory
101660 usd
CY2022Q4 us-gaap Other Inventory
OtherInventory
50790 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1812163 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
94823 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3631492 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1346372 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1664580 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
557346 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14483436 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11900672 usd
CY2023 us-gaap Depreciation
Depreciation
1107292 usd
CY2022 us-gaap Depreciation
Depreciation
484073 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-11747 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-9297 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1338889 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1268873 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2450 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2509 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
232508 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
232508 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
232508 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
232508 usd
CY2023Q4 WKSP Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
282674 usd
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
5215 usd
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
1313799 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
20781 usd
CY2023Q4 WKSP Prepaid Deposit
PrepaidDeposit
1492034 usd
CY2022Q4 WKSP Prepaid Deposit
PrepaidDeposit
699765 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1497249 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2034345 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
5215 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1313799 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
428300 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
299000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
299000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-14929000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12534000 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-746000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-627000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
14000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
41000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1901000 usd
CY2022 WKSP Income Tax Reconciliation Interest And Penalty
IncomeTaxReconciliationInterestAndPenalty
100000 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-13760000 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-13020000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-2889000 usd
CY2022 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-2734000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2889000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2734000 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
6005000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3784000 usd
CY2023Q4 WKSP Deferred Tax Assets Amortization And Depreciation
DeferredTaxAssetsAmortizationAndDepreciation
120000 usd
CY2022Q4 WKSP Deferred Tax Assets Amortization And Depreciation
DeferredTaxAssetsAmortizationAndDepreciation
-98000 usd
CY2023Q4 WKSP Deferred Tax Assets Change In Operating Lease
DeferredTaxAssetsChangeInOperatingLease
-3000 usd
CY2022Q4 WKSP Deferred Tax Assets Change In Operating Lease
DeferredTaxAssetsChangeInOperatingLease
-2000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1415000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
964000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
844600 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7537000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4648000 usd
CY2023Q4 WKSP Deferred Tax Assets Not Recognized
DeferredTaxAssetsNotRecognized
7537000 usd
CY2022Q4 WKSP Deferred Tax Assets Not Recognized
DeferredTaxAssetsNotRecognized
4648000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7537000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4648000 usd
CY2023Q4 WKSP Non Capital Losses Carried Forward
NonCapitalLossesCarriedForward
28594000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2034
NoncapitalLossesCarriedForwardExpirationYear2034
236000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2035
NoncapitalLossesCarriedForwardExpirationYear2035
529000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2036
NoncapitalLossesCarriedForwardExpirationYear2036
1130000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2037
NoncapitalLossesCarriedForwardExpirationYear2037
1531000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2038
NoncapitalLossesCarriedForwardExpirationYear2038
520000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2039
NoncapitalLossesCarriedForwardExpirationYear2039
193000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2040
NoncapitalLossesCarriedForwardExpirationYear2040
718000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2041
NoncapitalLossesCarriedForwardExpirationYear2041
3000000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2042
NoncapitalLossesCarriedForwardExpirationYear2042
4100000 usd
CY2023 WKSP Noncapital Losses Carried Forward Expiration Year2043
NoncapitalLossesCarriedForwardExpirationYear2043
3140000 usd
CY2023 WKSP Noncapital Losses Carried Forward Total
NoncapitalLossesCarriedForwardTotal
15097000 usd
CY2023 WKSP Noncapital Losses Never Expire
NoncapitalLossesNeverExpire
13497000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
28594000 usd
CY2023Q4 us-gaap Fair Value Concentration Of Risk Accounts Receivable
FairValueConcentrationOfRiskAccountsReceivable
0 usd
CY2022Q4 us-gaap Fair Value Concentration Of Risk Accounts Receivable
FairValueConcentrationOfRiskAccountsReceivable
0 usd
CY2023 us-gaap Reclassifications
Reclassifications
<p id="xdx_80D_eus-gaap--Reclassifications_zVn1G5JjDOT1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_82F_zNR0nM2oA5vj">Changes in Cash Flows from Operating Assets and Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfChangesInOperatingAssetsAndLiabilitiesTableTextBlock_zbDMJyChvBvc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The changes to the Company’s operating assets and liabilities for the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zIPBizBEg7Ae" style="display: none">Schedule of Changes in Operating Assets and Liabilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230101__20231231_zj6RATbVKKlf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20221231_zjXLEchaV9f6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsReceivable_iN_di_maIDIOCzg9T_zW5HxhjR0sC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Decrease (increase) in accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(400,521</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">83</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOtherReceivables_iN_di_maIDIOCzg9T_zeUfbtwKAD59" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Decrease (increase) in other receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">102,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(83,311</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInInventories_iN_di_maIDIOCzg9T_zSRlquHfQlD" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Decrease (increase) in inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,285,120</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(844,600</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_iN_di_maIDIOCzg9T_zpp3DyVDO1Zf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Decrease (increase) in prepaid expenses and deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(776,709</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(529,438</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--IncreaseDecreaseInLeaseLiability_iN_di_maIDIOCzg9T_zUv3gLaP138a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Increase (decrease) in lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1058">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,738</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_msIDIOCzg9T_zwGo0XYRRUq7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Increase (decrease) in payroll taxes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,010</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(112,189</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_msIDIOCzg9T_zbou4kVMDYOk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Increase (decrease) in accounts payable and accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(577,124</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">995,340</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingCapital_iNT_di_mtIDIOCzg9T_zKEAzBfIYr01" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in operating assets and liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,852,297</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(565,377</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
400521 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-83 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-102167 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
83311 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2285120 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
776709 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
529438 usd
CY2022 WKSP Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
-8738 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
85010 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-112189 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-577124 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
995340 usd
CY2023 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3852297 usd
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
565377 usd
CY2019 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
10000000 shares
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
50000 usd
CY2023Q4 WKSP Advanced Receivable For Stock Issuance
AdvancedReceivableForStockIssuance
24423 usd
CY2022Q4 WKSP Advanced Receivable For Stock Issuance
AdvancedReceivableForStockIssuance
24423 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
66308 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
90000 cad
CY2023 us-gaap Interest Costs Incurred
InterestCostsIncurred
2818 usd
CY2023 us-gaap Interest Costs Incurred
InterestCostsIncurred
3825 cad
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
917354 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1238055 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
328229 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
387329 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
608761 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
884146 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
488463 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
409179 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
515776 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
400130 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
400999 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
286395 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
277767 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
117158 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1082319 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
145329 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
936990 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
328229 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
608761 usd
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
28387 usd
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
40000 cad
CY2020 WKSP Debt Instrument Loan Forgiveness Percentage
DebtInstrumentLoanForgivenessPercentage
0.25 pure
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
28387 usd
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
40000 cad
CY2023Q1 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
7493 usd
CY2023Q1 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
10000 cad
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17689911 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17689911 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17078480 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17078480 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7669924 shares
CY2023Q4 us-gaap Share Price
SharePrice
89
CY2023 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
400000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11627924 shares
CY2023 WKSP Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y14D
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
1.44
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
5.50
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5063856 shares
CY2023 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y7M17D
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.96
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1162500 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3939924 shares
CY2022Q4 WKSP Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
5.84
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
5652827 shares
CY2021Q4 WKSP Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
5.14
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
8575000 shares
CY2023 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
1.09
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
130909 shares
CY2022 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
6.05
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
1593691 shares
CY2022 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Expired In Period Weighted Average Expirations Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredInPeriodWeightedAverageExpirationsPrice
-4.00
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
887000 shares
CY2023 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercise Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExerciseWeightedAverageExercisePrice
0.0001
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
250121 shares
CY2022 WKSP Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercise Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExerciseWeightedAverageExercisePrice
-2.00
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
11627924 shares
CY2023Q4 WKSP Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
2.78
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3939924 shares
CY2022Q4 WKSP Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
5.84
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
785000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.74
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
712500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.00
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4743356 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.80
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
72500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.21
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
464500 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.02
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5063856 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.96
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
785000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.74
CY2023 WKSP Rental Income Operating
RentalIncomeOperating
184564 usd
CY2022 WKSP Rental Income Operating
RentalIncomeOperating
213383 usd

Files In Submission

Name View Source Status
0001493152-24-011808-index-headers.html Edgar Link pending
0001493152-24-011808-index.html Edgar Link pending
0001493152-24-011808.txt Edgar Link pending
0001493152-24-011808-xbrl.zip Edgar Link pending
ex10-29.htm Edgar Link pending
ex19-1.htm Edgar Link pending
ex19-1_001.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wksp-20231231.xsd Edgar Link pending
wksp-20231231_def.xml Edgar Link unprocessable
wksp-20231231_lab.xml Edgar Link unprocessable
wksp-20231231_pre.xml Edgar Link unprocessable
wksp-20231231_cal.xml Edgar Link unprocessable